Related Experiment Video
Updated: May 15, 2026

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
Exploiting selected Mur enzyme characteristics for antibacterial drug design
Gizachew Muluneh Amera1, Giulia Canarutto2, Monika Jain3
1Computational Biology Group, International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34149 Trieste, Italy; The Division of Bioinformatics and Database Management, Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia; School of Bioscience and Technology, Wollo University, Dessie, Ethiopia.
Abstract:
Bacterial species demonstrate remarkable adaptability in hostile environments and develop resistance to multiple antibacterial molecules, creating significant challenges for infection treatment in clinical settings. At the core of this challenge lies peptidoglycan, a key component in cell wall synthesis that provides both structural integrity and environmental protection for bacterial cells. The peptidoglycan biosynthesis pathway operates across three distinct cellular compartments: the cytoplasm, membrane, and periplasmic space. The process initiates in the cytoplasm with nucleotide precursor formation, where Mur family enzymes transform UDPGlcNAc into UDP-MurNAc-pentapeptide (UDP-Mpp). Simultaneously, undecaprenyl phosphate is produced on the cytoplasmic side (inner membrane), with membrane proteins MraY and MurG serving as essential catalysts for lipid I and lipid II formation. This review provides updated insights into Mur family proteins by focusing on their physicochemical properties, evolutionary relationships, post-translational modifications (PTMs), structural characteristics (functional domains and binding site properties including number and type of binding site residues) and dynamic behaviour. Given the limited commercial availability of peptidoglycan precursors, special emphasis is placed on understanding these enzymes role in peptidoglycan biosynthesis. Furthermore, the review emphasizes existing inhibitors and current research efforts to develop novel targeted compounds based on structure-activity relationships of known inhibitors. The information presented in this review paves the way for developing promising antibacterial therapeutics designed to tackle the challenges posed by multidrug-resistant (MDR) and extensively drug-resistant (XDR) pathogenic bacterial strains.
Insights
This review details bacterial Mur enzymes, crucial for peptidoglycan biosynthesis and antibiotic resistance. Understanding these enzymes and their inhibitors aids in developing new treatments for multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacterial infections.
Area of Science:
- Microbiology
- Biochemistry
- Drug Discovery
Background:
- Bacterial adaptability and resistance to antibiotics pose clinical challenges.
- Peptidoglycan, essential for bacterial cell walls, is synthesized via a multi-compartment pathway.
- Mur family enzymes are central to synthesizing peptidoglycan precursors.
Purpose of the Study:
- To provide updated insights into Mur family proteins.
- To explore their physicochemical properties, evolution, modifications, structure, and dynamics.
- To highlight their role in peptidoglycan biosynthesis and potential as therapeutic targets.
Main Methods:
- Review of existing literature on Mur family proteins.
- Analysis of structural characteristics and binding site properties.
- Examination of known inhibitors and structure-activity relationships.
Main Results:
- Detailed characterization of Mur family enzymes' properties and functions.
- Identification of key structural features and dynamic behaviors.
- Comprehensive overview of current inhibitors and drug development strategies.
Conclusions:
- Mur enzymes are critical targets for antibacterial drug development.
- Understanding enzyme structure-activity relationships facilitates novel inhibitor design.
- This knowledge aids in combating multidrug-resistant and extensively drug-resistant bacterial strains.
More Related Videos
Related Concept Videos
Antibiotic Selection
Development of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Mechanism of Antibiotic Resistance in MRSA

